Clearpoint Neuro Inc Revenue Growth Rates (CLPT), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Clearpoint Neuro Inc   (NASDAQ: CLPT)
 

CLPT's Revenue Growth by Quarter and Year

Clearpoint Neuro Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/CLPT/growth
https://api.csimarket.com/api/v1/companies/CLPT/fundamentals
https://api.csimarket.com/api/v1/companies/CLPT/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
CLPT Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 12.08
2nd Quarter June 10.88
1st Quarter March 12.13
FY 35.09

CLPTs Annual Revenue
Clearpoint Neuro Inc 's Revenue in the fiscal year 2025 $ 36.97 millions
Clearpoint Neuro Inc 's Revenue in the fiscal year 2024 $ 31.39 millions
Clearpoint Neuro Inc 's Revenue in the fiscal year 2023 $ 23.96 millions
Clearpoint Neuro Inc 's Revenue in the fiscal year 2022 $ 20.55 millions
Clearpoint Neuro Inc 's Revenue in the fiscal year 2021 $ 16.30 millions




CLPT Revenue third quarter 2026 Y/Y Growth Comment
Clearpoint Neuro Inc achieved in the third quarter 2026, above Company average Revenue growth of 36.29% year on year, to $ 12.08 millions.

Looking into third quarter 2026 results within Medical Equipment & Supplies industry 66 other companies have achieved higher Revenue growth. While Clearpoint Neuro Inc ' s Revenue rise of 36.29% ranks overall at the positon no. 1136 in the third quarter 2026.


CLPT Revenue ( Y/Y Growth %) 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 36.29 %
2nd Quarter June 18 %
1st Quarter March 42.87 %
FY   -

Financial Statements
Clearpoint Neuro Inc 's third quarter 2026 Revenue $ 12.08 millions CLPT's Income Statement
Clearpoint Neuro Inc 's third quarter 2025 Revenue $ 8.86 millions Quarterly CLPT's Income Statement


CLPT Revenue (Quarter on Quarter Growth %)

 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 10.98 %
2nd Quarter June -10.31 %
1st Quarter March 16.52 %
FY (Year on Year)   -


Back to CLPT Growth rate Comparisons >> Back to CLPT Growth rate Comparisons >>


Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #67
Healthcare Sector #219
Overall #1136

Revenue Y/Y Growth Statistics
High Average Low
111.36 % 22.4 % -48.1 %
(Jun 30 2016)   (Mar 31 2014)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #67
Healthcare Sector #219
Overall #1136
Revenue Y/Y Growth Statistics
High Average Low
111.36 % 22.4 % -48.1 %
(Jun 30 2016)   (Mar 31 2014)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Clearpoint Neuro Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
64.89 % 7.24 % -55.51 %
(Sep 30 2013)  


CLPT's III. Quarter Q/Q Revenue Comment
Clearpoint Neuro Inc achieved in the III. Quarter 2026 above company average sequential Revenue rise of 10.98%, to $ 12.08 millions, from $10.88 millions in the second quarter.
CLPT is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Equipment & Supplies industry 116 other companies have achieved higher Revenue quarter on quarter growth. While Clearpoint Neuro Inc 's Revenue growth quarter on quarter, overall rank is 2877.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #117
Healthcare Sector #367
Overall #2877
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #117
Healthcare Sector #367
Overall #2877
Revenue Q/Q Growth Statistics
High Average Low
64.89 % 7.24 % -55.51 %
(Sep 30 2013)  


CLPT's III. Quarter Q/Q Revenue Comment
Clearpoint Neuro Inc achieved in the III. Quarter 2026 above company average sequential Revenue rise of 10.98%, to $ 12.08 millions, from $10.88 millions in the second quarter.
CLPT is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Equipment & Supplies industry 116 other companies have achieved higher Revenue quarter on quarter growth. While Clearpoint Neuro Inc 's Revenue growth quarter on quarter, overall rank is 2877.


Clearpoint Neuro Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2026)		 12 Months Ending (Jun 30 2026) 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025)
Cumulative Revenue 12 Months Ending $ 45.49
Y / Y Revenue Growth (TTM) 32.51 %
Year on Year Revenue Growth Overall Ranking # 878
Seqeuential Revenue Change (TTM) 7.6 %
Seq. Revenue Growth (TTM) Overall Ranking # 2170


Cumulative Revenue growth Comment
Clearpoint Neuro Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 32.51% year on year, to $ 45 millions if the fiscal year would have ended in Sep 30 2026.
Clearpoint Neuro Inc 's trailing twelve months Revenue growth was higher than company's average 19.22% and higher than 25.86% growth in Jun 30 2026.
But from twelve months ended Jun 30 2026 rise was beneth at 7.6 % from $42.28 millions achieved in the period from Jun 30 2026 to Sep 30 2025.
We witness drop-off happening, more obvious observing the usual Q/Q TTM historic rise that is stronger at19.22%.

In the Healthcare sector 177 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 571 to 878.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 116
Healthcare Sector # 178
Overall # 878

Revenue TTM Y/Y Growth Statistics
High Average Low
53.27 %
 19.22 %
-34.69 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 116
Sector # 321
S&P 500 # 2170
Cumulative Revenue growth Comment
Clearpoint Neuro Inc saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 32.51% year on year, to $ 45 millions if the fiscal year would have ended in Sep 30 2026.
Clearpoint Neuro Inc 's trailing twelve months Revenue growth was higher than company's average 19.22% and higher than 25.86% growth in Jun 30 2026.
But from twelve months ended Jun 30 2026 rise was beneth at 7.6 % from $42.28 millions achieved in the period from Jun 30 2026 to Sep 30 2025.
We witness drop-off happening, more obvious observing the usual Q/Q TTM historic rise that is stronger at19.22%.
The momentum is even more impressive from twelve months ended Jun 30 2026 exhibited at 7.6 % increase from $42.28 millions in the period from Jun 30 2026 to Sep 30 2025.

In the Healthcare sector 177 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 571 to 878.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 116
Healthcare Sector # 178
Overall # 878

Revenue TTM Y/Y Growth Statistics
High Average Low
53.27 %
19.22 %
-34.69 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 116
Sector # 321
S&P 500 # 2170




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CLPT's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue rise for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Tg Therapeutics Inc 60.74%$ 60.743 millions
Heartflow Inc 60.42%$ 60.425 millions
Glaukos Corp59.02%$ 59.021 millions
X4 Pharmaceuticals Inc58.64%$ 58.640 millions
Kiniksa Pharmaceuticals International Plc58.12%$ 58.121 millions
Envoy Medical Inc 57.14%$ 57.143 millions
Humacyte Inc 55.21%$ 55.208 millions
Butterfly Network Inc 53.45%$ 53.453 millions
Avita Medical Inc 53.05%$ 53.054 millions
Immunitybio inc 52.34%$ 52.338 millions
Axsome Therapeutics Inc 51.87%$ 51.873 millions
Innovative Eyewear Inc 51.12%$ 51.123 millions
Strata Critical Medical Inc 50.27%$ 50.272 millions
Madrigal Pharmaceuticals Inc 50.13%$ 50.127 millions
Immucell Corporation49.91%$ 49.912 millions
Hims and Hers Health Inc 48.88%$ 48.877 millions
Maxcyte inc 48.66%$ 48.660 millions
Billiontoone Inc 47.43%$ 47.431 millions
Arcutis Biotherapeutics Inc 45.05%$ 45.052 millions
Zevra Therapeutics Inc 44.86%$ 44.864 millions
Xeris Biopharma Holdings Inc 44.16%$ 44.158 millions
Nephros Inc 43.60%$ 43.602 millions
Cardiff Oncology Inc 42.50%$ 42.500 millions
Neurocrine Biosciences Inc 41.24%$ 41.238 millions
Transmedics Group Inc 41.15%$ 41.149 millions
Uniqure N v 40.39%$ 40.394 millions
Harrow Inc 40.00%$ 40.001 millions
Mirum Pharmaceuticals Inc 39.63%$ 39.629 millions
Caredx Inc 39.29%$ 39.285 millions
Halozyme Therapeutics Inc 39.15%$ 39.154 millions


About Clearpoint Neuro Inc Revenue Growth Rates (CLPT), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Clearpoint Neuro Inc (CIK 1285550).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001193125-26-436412
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Clearpoint Neuro Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.